June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
OCT Characteristics Among Subjects Implanted with the Argus II Retinal Prosthesis System; the Argus II OCT Study Group
Author Affiliations & Notes
  • Catherine Hoeppner
    Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States
  • Natalia F Callaway
    Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States
  • Ninel Gregori
    Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States
  • Byron L Lam
    Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, United States
  • Hossein Ameri
    University of Southern California, Los Angeles, California, United States
  • Albert J Augustin
    Städtisches Klinikum, Augenklinik, Karlsruhe, Karlsruhe, Germany
  • Allen Ho
    Wills Eye Institute, Philadelphia, Pennsylvania, United States
  • Raymond Iezzi
    Mayo Clinic, Rochester, Minnesota, United States
  • Thiran Jayasundera
    University of Michigan Kellogg Eye Center, Ann Arbor, Michigan, United States
  • Gregg Kokame
    Retina Consultants of Hawaii, Aiea, Hawaii, United States
  • Jennifer I Lim
    University of Illinois at Chicago, Chicago, Illinois, United States
  • Peter Szurman
    Augenklinik Knappschaftsklinikum Saar, Sulzbach, Germany
  • Lejla Vajzovic
    Duke Eye Center, Durham, North Carolina, United States
  • Peter MH Wiedemann
    Klinik und Poliklinik für Augenheilkunde, Universitätsklinikum Leipzig, Leipzig, Germany
  • Jiong Yan
    Emory University, Atlanta, Georgia, United States
  • Footnotes
    Commercial Relationships   Catherine Hoeppner, None; Natalia Callaway, None; Ninel Gregori, Second Sight Medical Products, Inc. (C); Byron Lam, None; Hossein Ameri, None; Albert Augustin, None; Allen Ho, None; Raymond Iezzi, None; Thiran Jayasundera, None; Gregg Kokame, None; Jennifer Lim, None; Peter Szurman, None; Lejla Vajzovic, None; Peter Wiedemann, None; Jiong Yan, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 4267. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Catherine Hoeppner, Natalia F Callaway, Ninel Gregori, Byron L Lam, Hossein Ameri, Albert J Augustin, Allen Ho, Raymond Iezzi, Thiran Jayasundera, Gregg Kokame, Jennifer I Lim, Peter Szurman, Lejla Vajzovic, Peter MH Wiedemann, Jiong Yan; OCT Characteristics Among Subjects Implanted with the Argus II Retinal Prosthesis System; the Argus II OCT Study Group. Invest. Ophthalmol. Vis. Sci. 2017;58(8):4267.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The Argus II retinal prosthesis system is the first FDA-approved epiretinal implant aimed to partially restore vision in patients with outer retinal dystrophy, most often retinitis pigmentosa. There is a paucity of data regarding changes in retinal anatomy after implantation. We performed a retrospective review of retinal images of Argus II recipients to evaluate the macular structure after implantation.

Methods : US and European surgical sites participating in the Post-market approval study were contacted for voluntary participation (all participating investigators will be listed as the Argus II OCT Study Group). Baseline demographics, fundus photographs and OCT images obtained preoperatively and 1, 3, 6, and 12 months after implantation were evaluated. Images were reviewed for macular edema, epiretinal membrane (ERM), optic nerve overlap as well as the distance of the array to the inner retinal surface. Frequency distributions were used to describe the data. Images that were deemed unreadable by two separate investigators were excluded.

Results : Among post-approval study investigators, 86% (n=24) agreed to participate. The patients were implanted between January 2014 and October 2016. Participants were 68% male with a mean age at time of implantation of 62.3 years (SD 10.9). ERM was not seen in any patients preoperatively and was seen in 50% at one year post-implant. Macular edema was absent in all patients preoperatively and was present in all available one-year images (100%). A portion of the electrode array overlapped the optic nerve in the majority of subjects, however, the overlap was usually limited to the plastic bumper without direct nerve-electrode contact. The mean distance from the central electrode to the internal limiting membrane was 182 microns.

Conclusions : Following Argus II retinal prosthesis implantation, macular edema and ERM formation commonly occurred. Some degree of array-optic nerve overlap was seen in most subjects, however, the electrodes were usually not in direct contact with the nerve. Future work will be done to evaluate the gap between the array and the inner retina and to correlate that distance with stimulation thresholds and impedance values. The ultimate goal is to gain knowledge that may be helpful for optimal device implantation and array modifications to maximize functionality.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×